UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 8-K

___________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): June 1626, 2026

___________________________________

DOCGO INC.

(Exact name of registrant as specified in its charter)

___________________________________

Delaware

001-39618

85-2515483

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

685 Third Avenue, 9th Floor, New York, New York

10017

(Address of principal executive offices)

(Zip Code)

(844) 443-6246

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common stock, par value $0.0001 per share

DCGO

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 57.~~07 Submission~~01 ofRegulation ~~Matters~~FD ~~to a Vote of Security Holders~~Disclosure.

On June 1626, 2026, the Board of Directors of DocGo Inc. (the “Company”) ~~held~~approved ~~its~~an ~~2026~~extension ~~Annual Meeting~~ of ~~Stockholders (~~the ~~“Annual~~expiration ~~Meeting”)~~date atof ~~12:00~~the ~~p.m.~~Company’s ~~Eastern~~current ~~Time.~~share Asrepurchase ofprogram ~~the~~(“Repurchase ~~close~~Program”) offrom ~~business~~June on30, ~~April~~2026 20to December 31, 2026,. ~~the~~As ~~record~~previously ~~date~~disclosed, ~~for~~pursuant to the ~~Annual~~Repurchase ~~Meeting~~Program, ~~there~~the ~~were~~Company ~~98,778,413~~may ~~shares~~purchase ofup ~~common~~to ~~stock~~$26 ~~entitled~~million toin ~~vote~~shares atof the ~~Annual~~Company’s ~~Meeting~~common stock. ~~The~~Other ~~results~~than the extension of the ~~matters~~program’s ~~voted~~expiration ~~upon~~date, atno ~~the~~changes ~~Annual~~were ~~Meeting~~made ~~were~~to asthe ~~follows:~~Repurchase Program.

~~1. Election~~Under the terms of the ~~two~~Repurchase ~~Class~~Program, IIas ~~director~~extended, ~~nominees~~the Company may continue to ~~serve~~purchase ~~until~~shares ~~the~~of ~~2029~~its ~~Annual~~common ~~Meeting~~stock ofon ~~Stockholders~~a ~~and~~discretionary ~~until~~basis ~~their~~from ~~successors~~time ~~are~~to ~~duly~~time ~~elected~~through open market repurchases or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs, in each case, during an “open window” and ~~qualified:~~when the Company does not possess material non-public information.

Director Nominee	Votes For	Votes Withheld	Broker Non-Votes
Vina Leite	31,241,093	18,924,442	21,849,313
James M. Travers	25,062,607	25,102,928	21,849,313

The timing and actual number of shares repurchased under the Repurchase Program will depend on a variety of factors, including stock price, trading volume, market conditions, corporate and regulatory requirements and other general business considerations. The Repurchase Program may be modified, suspended or discontinued at any time without prior notice.

~~Pursuant~~Repurchases tounder the ~~foregoing~~Repurchase ~~votes,~~Program ~~the~~may ~~two~~be ~~nominees~~funded ~~listed~~from ~~above were elected to serve on~~ the Company’s ~~Board~~existing ofcash ~~Directors.~~and ~~There~~cash ~~were~~equivalents, nofuture ~~additional~~cash ~~director~~flow ~~nominations~~or ~~brought~~proceeds ~~before~~of ~~the~~borrowings ~~Annual~~or ~~Meeting~~debt offerings.

2The information in Item 7. To01 ~~approve~~of this Current Report on aForm ~~non~~8-~~binding~~K is being furnished and shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, ~~advisory~~as ~~basis~~amended (the ~~compensation~~“Exchange Act”), nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the ~~Company’s~~Exchange ~~named~~Act, ~~executive~~except ~~officers:~~as shall be expressly set forth by specific reference to such filing.

Votes For			Votes Against			Abstentions			Broker Non-Votes
39,768,972			10,213,238			183,325			21,849,313

Pursuant to the foregoing vote, the stockholders approved on a non-binding, advisory basis the compensation of the Company’s named executive officers.

3. To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 to be determined in the sole discretion of the Company’s Board of Directors.

Votes For			Votes Against			Abstentions			Broker Non-Votes
66,141,612			5,673,628			199,608			—

Pursuant to the foregoing vote, the stockholders approved the proposed reverse stock split.

4. To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Charter”) regarding the waiver of corporate opportunities (the “Corporate Opportunity Amendment”):

Votes For			Votes Against			Abstentions			Broker Non-Votes
40,810,518			8,726,933			628,084			21,849,313

Pursuant to the foregoing vote, stockholders representing the requisite number of shares did not approve the Corporate Opportunity Amendment necessary to amend the Charter.

5. To approve an amendment to the Charter to limit the liability of certain officers as permitted by Delaware law (the “Officer Exculpation Amendment”):

Votes For			Votes Against			Abstentions			Broker Non-Votes
43,427,921			5,990,544			747,070			21,849,313

Pursuant to the foregoing vote, stockholders representing the requisite number of shares did not approve the Officer Exculpation Amendment necessary to amend the Charter.

6. Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026:

Votes For			Votes Against			Abstentions			Broker Non-Votes
67,639,242			3,874,903			500,703			—

Pursuant to the foregoing vote, the stockholders ratified the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOCGO INC. By: /s/ ~~Ely~~Norman D.Rosenberg ~~Tendler~~ Name: ~~Ely~~Norman D.Rosenberg ~~Tendler~~ Title: ~~General~~Chief ~~Counsel~~Financial Officer and ~~Secretary~~Treasurer

Date: ~~June~~July 182, 2026

Filing Compare · DocGo Inc.